Industrial, Manufacturing & Heavy Industry Market News

Research details developments in the neuromodulation market

Industrial Market Research

This neuromodulation market research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies.

- Advertising -

Complete report available at www.marketreportsonline.com/502662.html.

The research report provides analysis and information according to categories such as market segments, application, technology, geographies, companies and competitive landscape.

- Advertising -

The report concludes with the profiles of major players in the global neuromodulation such as Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro. The major market players are evaluated on various parameters such as company overview, product portfolio, and sales analysis of neuromodulation segment from 2010 to 2021.

The report also entails major drivers and challenges of neuromodulation market.

The Global market for Neuromodulation is projected to reach more than US$5 Billion by the end of 2021 growing at a CAGR of around XX% from 2016 to 2021.

Market growth can be attributed to factors such as rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by the players. In addition, rapid advances in the field of neuromodulation and development of minimally invasive techniques have greatly expanded the market.

High cost of treatment and negative social perception is restraining the growth of neuromodulation market.

Report at www.marketreportsonline.com/contacts/name=502662.

North America is seen as the dominant player in the neuromodulation market followed by Europe, Asia–Pacific, and rest of the world (RoW) in 2015. In the coming years, the neuromodulation market is expected to witness the highest growth rate in the Asian region, with emphasis on India, China, and Japan.

These countries are expected to increase revenues for the manufacturers of devices involved in neuromodulation.

Spinal cord stimulation segment dominated the neuromodulation market with more than XX% share in 2015. But its market share will dwindle in the forecasting period due to the highest growth rate of deep brain stimulation.

It is expected that deep brain stimulation will grasp nearly 20% market share by the year end of 2021.

Chronic Pain is identified as the largest application segment of the neuromodulation market. Urinary and Fecal Incontinence(UFI) is the second leading segment for neuromodulation market.

Refractory epilepsy stands at the third spot with more than XX% share in 2015. Parkinson’s disease holds the fourth highest share being followed by Gastroparesis.

Essential Tremor and Dystonia are the other leading application segment for neuromodulation market.

Further, prudent analysis has been done on the competitor’s part, where three major players grab XX% of the global market by revenue. Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro are the key influencers with their products in the Neuromodulation market.

Merger & acquisitions, partnerships, collaborations and extending distribution networks are few important factors for their dominance.

 

News From

MarketReportsOnline - Industry Research Analysis StoreMarketReportsOnline
Category: Market Research Publishers and RetailersCompany about: MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.
This email address is being protected from spambots. You need JavaScript enabled to view it.